UNITED STATES

SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

 

FORM 8-K

 

CURRENT REPORT
Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

 

Date of Report (Date of earliest event reported): August 4, 2015

 

 

ROCKWELL MEDICAL, INC.
(Exact name of registrant as specified in its charter)

 

 

 

Michigan 000-23661 38-3317208
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number)    Identification No.)

 

 

30142 Wixom Road, Wixom, Michigan 48393
(Address of principal executive offices) (Zip Code)
   

 

Registrant's telephone number, including area code (248) 960-9009

 

 

Not applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) 

 
 

Item 2.02 Results of Operations and Financial Condition.

 

On August 4, 2015, the Company issued the press release attached hereto as Exhibit 99.1, announcing its financial results for the quarter ended June 30, 2015.

 

Item 9.01 Financial Statements and Exhibits.

 

The following exhibit is furnished with this Form 8-K:

 

 Exhibit  Description
     
99.1  Press Release dated August 4, 2015.

 

 
 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

  ROCKWELL MEDICAL, INC.
     
     
August 4, 2015 By: /S/ Thomas E. Klema
   

Thomas E. Klema

Its: Chief Financial Officer

 

 

 

 

 

 
 

EXHIBIT INDEX

 

 Exhibit  Description
     
99.1  Press Release dated August 4, 2015.